annual net income:
-$569.18M+$37.46M(+6.17%)Summary
- As of today (July 7, 2025), RARE annual net profit is -$569.18 million, with the most recent change of +$37.46 million (+6.17%) on December 31, 2024.
- During the last 3 years, RARE annual net income has fallen by -$115.16 million (-25.36%).
- RARE annual net income is now -8210.45% below its all-time high of -$6.85 million, reached on December 31, 2011.
Performance
RARE Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$151.08M-$17.70M(-13.27%)Summary
- As of today (July 7, 2025), RARE quarterly net profit is -$151.08 million, with the most recent change of -$17.70 million (-13.27%) on March 31, 2025.
- Over the past year, RARE quarterly net income has increased by +$19.60 million (+11.49%).
- RARE quarterly net income is now -599.39% below its all-time high of $30.25 million, reached on March 31, 2018.
Performance
RARE quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$549.58M+$19.60M(+3.44%)Summary
- As of today (July 7, 2025), RARE TTM net profit is -$549.58 million, with the most recent change of +$19.60 million (+3.44%) on March 31, 2025.
- Over the past year, RARE TTM net income has increased by +$63.77 million (+10.40%).
- RARE TTM net income is now -11047.65% below its all-time high of -$4.93 million, reached on December 31, 2012.
Performance
RARE TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RARE Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.2% | +11.5% | +10.4% |
| 3 y3 years | -25.4% | +0.8% | -16.9% |
| 5 y5 years | -41.3% | -26.9% | -82.9% |
RARE Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.4% | +19.5% | -22.6% | +38.4% | -8.6% | +23.8% |
| 5 y | 5-year | -205.1% | +19.5% | -696.8% | +38.4% | -194.6% | +23.8% |
| alltime | all time | -8210.5% | +19.5% | -599.4% | +38.4% | <-9999.0% | +23.8% |
RARE Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$151.08M(+13.3%) | -$549.58M(-3.4%) |
| Dec 2024 | -$569.18M(-6.2%) | -$133.38M(-0.1%) | -$569.18M(+1.8%) |
| Sep 2024 | - | -$133.52M(+1.5%) | -$558.99M(-4.5%) |
| Jun 2024 | - | -$131.60M(-22.9%) | -$585.12M(-4.6%) |
| Mar 2024 | - | -$170.68M(+38.6%) | -$613.35M(+1.1%) |
| Dec 2023 | -$606.64M(-14.2%) | -$123.19M(-22.8%) | -$606.64M(-4.5%) |
| Sep 2023 | - | -$159.65M(-0.1%) | -$635.28M(-11.9%) |
| Jun 2023 | - | -$159.83M(-2.5%) | -$720.74M(+0.2%) |
| Mar 2023 | - | -$163.97M(+8.0%) | -$719.07M(+1.6%) |
| Dec 2022 | -$707.42M(+55.8%) | -$151.83M(-38.1%) | -$707.42M(+4.3%) |
| Sep 2022 | - | -$245.11M(+55.0%) | -$678.05M(+34.0%) |
| Jun 2022 | - | -$158.16M(+3.8%) | -$505.94M(+7.6%) |
| Mar 2022 | - | -$152.32M(+24.4%) | -$470.20M(+3.6%) |
| Dec 2021 | -$454.02M(+143.4%) | -$122.46M(+67.8%) | -$454.02M(+27.7%) |
| Sep 2021 | - | -$73.00M(-40.4%) | -$355.58M(+1.2%) |
| Jun 2021 | - | -$122.43M(-10.1%) | -$351.43M(+72.5%) |
| Mar 2021 | - | -$136.14M(+467.0%) | -$203.68M(+9.2%) |
| Dec 2020 | -$186.57M(-53.7%) | -$24.01M(-65.1%) | -$186.57M(-27.2%) |
| Sep 2020 | - | -$68.84M(-372.0%) | -$256.36M(-14.7%) |
| Jun 2020 | - | $25.32M(-121.3%) | -$300.51M(-29.3%) |
| Mar 2020 | - | -$119.03M(+26.9%) | -$425.00M(+5.5%) |
| Dec 2019 | -$402.73M(+103.8%) | -$93.81M(-17.0%) | -$402.73M(+1.5%) |
| Sep 2019 | - | -$112.99M(+13.9%) | -$396.75M(+6.9%) |
| Jun 2019 | - | -$99.17M(+2.5%) | -$371.06M(+14.3%) |
| Mar 2019 | - | -$96.76M(+10.2%) | -$324.62M(+64.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$197.61M(-34.6%) | -$87.83M(+0.6%) | -$197.61M(+3.2%) |
| Sep 2018 | - | -$87.31M(+65.6%) | -$191.52M(+4.4%) |
| Jun 2018 | - | -$52.73M(-274.3%) | -$183.43M(-9.9%) |
| Mar 2018 | - | $30.25M(-137.0%) | -$203.60M(-32.6%) |
| Dec 2017 | -$302.14M(+22.9%) | -$81.73M(+3.2%) | -$302.14M(+3.6%) |
| Sep 2017 | - | -$79.23M(+8.7%) | -$291.69M(+5.2%) |
| Jun 2017 | - | -$72.89M(+6.7%) | -$277.38M(+6.1%) |
| Mar 2017 | - | -$68.29M(-4.2%) | -$261.41M(+6.3%) |
| Dec 2016 | -$245.87M(+68.8%) | -$71.29M(+9.8%) | -$245.87M(+7.0%) |
| Sep 2016 | - | -$64.91M(+14.0%) | -$229.81M(+12.6%) |
| Jun 2016 | - | -$56.92M(+7.9%) | -$204.13M(+15.3%) |
| Mar 2016 | - | -$52.76M(-4.5%) | -$177.00M(+21.5%) |
| Dec 2015 | -$145.62M(+143.5%) | -$55.22M(+40.8%) | -$145.62M(+35.9%) |
| Sep 2015 | - | -$39.23M(+31.7%) | -$107.14M(+27.9%) |
| Jun 2015 | - | -$29.79M(+39.3%) | -$83.75M(+24.0%) |
| Mar 2015 | - | -$21.38M(+27.7%) | -$67.55M(+13.0%) |
| Dec 2014 | -$59.80M(+70.5%) | -$16.74M(+5.6%) | -$59.80M(+10.0%) |
| Sep 2014 | - | -$15.85M(+16.7%) | -$54.38M(+15.8%) |
| Jun 2014 | - | -$13.59M(-0.3%) | -$46.96M(+11.9%) |
| Mar 2014 | - | -$13.63M(+20.4%) | -$41.97M(+19.7%) |
| Dec 2013 | -$35.07M(+114.7%) | -$11.32M(+34.3%) | -$35.07M(+22.3%) |
| Sep 2013 | - | -$8.43M(-1.9%) | -$28.68M(+41.6%) |
| Jun 2013 | - | -$8.59M(+27.5%) | -$20.25M(+73.6%) |
| Mar 2013 | - | -$6.74M(+36.6%) | -$11.66M(+136.6%) |
| Dec 2012 | -$16.33M(+138.5%) | -$4.93M | -$4.93M |
| Dec 2011 | -$6.85M | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual net profit?
- What is the all time high annual net income for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual net income year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly net profit?
- What is the all time high quarterly net income for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly net income year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM net profit?
- What is the all time high TTM net income for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM net income year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual net profit?
The current annual net income of RARE is -$569.18M
What is the all time high annual net income for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual net profit is -$6.85M
What is Ultragenyx Pharmaceutical Inc. annual net income year-on-year change?
Over the past year, RARE annual net profit has changed by +$37.46M (+6.17%)
What is Ultragenyx Pharmaceutical Inc. quarterly net profit?
The current quarterly net income of RARE is -$151.08M
What is the all time high quarterly net income for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly net profit is $30.25M
What is Ultragenyx Pharmaceutical Inc. quarterly net income year-on-year change?
Over the past year, RARE quarterly net profit has changed by +$19.60M (+11.49%)
What is Ultragenyx Pharmaceutical Inc. TTM net profit?
The current TTM net income of RARE is -$549.58M
What is the all time high TTM net income for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM net profit is -$4.93M
What is Ultragenyx Pharmaceutical Inc. TTM net income year-on-year change?
Over the past year, RARE TTM net profit has changed by +$63.77M (+10.40%)